Nanobiotics: Challenging the anti-microbial perspective - The game changer?

D. Narang, Jeevan Singh Tityal, Amit Jain, Reena Kulshreshtra, F. Khan
{"title":"Nanobiotics: Challenging the anti-microbial perspective - The game changer?","authors":"D. Narang, Jeevan Singh Tityal, Amit Jain, Reena Kulshreshtra, F. Khan","doi":"10.21746/IJBIO.2017.6.10.2","DOIUrl":null,"url":null,"abstract":"Antibiotics are the most important medical inventions in human history and are the invaluable weapons to fight against various infectious diseases. Multi drug resistant microorganisms are becoming a serious issue and increasingly public health problem in present day scenario. Antibiotics are becoming less useful due to increasing bacterial resistance. Development of new and more powerful antibiotics leading to drastic pathogens response by developing resistance to the point where the most powerful drugs in our arsenal are no longer effective against them. New strategies for the management of bacterial diseases are urgently needed and nanomaterials can be a very promising approach. Nanobiotics uses nano-sized tools for the successful management bacterial diseases and to gain increased understanding of the complex underlying patho-physiology of disease. (European Science Foundation. Forward Look Nanomedicine: An EMRC Consensus Opinion 2005. Available online: http://www.esf.org (accessed on 15 July 2017). The application of nanotechnologies to medicine, or nanomedicine, which has already demonstrated its tremendous impact on the pharmaceutical and biotechnology industries, is rapidly becoming a major driving force behind ongoing changes in the antimicrobial field. Present review providing important insights on nanobiotics, and their preparation, mechanism of action, as well as perspectives on the opportunities and challenges in nanobiotics.","PeriodicalId":13765,"journal":{"name":"International Journal of Bioassays","volume":"30 1","pages":"5518-5524"},"PeriodicalIF":0.0000,"publicationDate":"2017-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Bioassays","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21746/IJBIO.2017.6.10.2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Antibiotics are the most important medical inventions in human history and are the invaluable weapons to fight against various infectious diseases. Multi drug resistant microorganisms are becoming a serious issue and increasingly public health problem in present day scenario. Antibiotics are becoming less useful due to increasing bacterial resistance. Development of new and more powerful antibiotics leading to drastic pathogens response by developing resistance to the point where the most powerful drugs in our arsenal are no longer effective against them. New strategies for the management of bacterial diseases are urgently needed and nanomaterials can be a very promising approach. Nanobiotics uses nano-sized tools for the successful management bacterial diseases and to gain increased understanding of the complex underlying patho-physiology of disease. (European Science Foundation. Forward Look Nanomedicine: An EMRC Consensus Opinion 2005. Available online: http://www.esf.org (accessed on 15 July 2017). The application of nanotechnologies to medicine, or nanomedicine, which has already demonstrated its tremendous impact on the pharmaceutical and biotechnology industries, is rapidly becoming a major driving force behind ongoing changes in the antimicrobial field. Present review providing important insights on nanobiotics, and their preparation, mechanism of action, as well as perspectives on the opportunities and challenges in nanobiotics.
纳米生物制剂:挑战抗微生物视角——游戏规则改变者?
抗生素是人类历史上最重要的医学发明,是对抗各种传染病的宝贵武器。多重耐药微生物已成为当今世界日益严重的公共卫生问题。由于细菌耐药性的增加,抗生素的作用越来越小。开发新的和更强效的抗生素,导致病原体产生激烈的反应,产生耐药性,以至于我们武器库中最有效的药物不再对它们有效。目前迫切需要管理细菌性疾病的新策略,而纳米材料可能是一种非常有前途的方法。纳米生物使用纳米工具成功管理细菌疾病,并增加对疾病复杂的潜在病理生理学的理解。(欧洲科学基金会。前瞻性纳米医学:EMRC共识意见2005。可在线查阅:http://www.esf.org(2017年7月15日访问)。纳米技术在医学上的应用,或纳米医学,已经证明了它对制药和生物技术产业的巨大影响,正迅速成为抗菌领域持续变化背后的主要推动力。本文综述了纳米生物制剂、纳米生物制剂的制备、纳米生物制剂的作用机制以及纳米生物制剂的机遇和挑战。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信